{"organizations": [], "uuid": "19d137660eeecf0a6837e645e2d0203884cfaba9", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-onconova-therapeutics-announces-pr/brief-onconova-therapeutics-announces-pricing-of-25-mln-upsized-underwritten-public-offering-idUSASC09Y0G", "country": "US", "domain_rank": 408, "title": "BRIEF-Onconova Therapeutics Announces Pricing Of $25 Mln Upsized Underwritten Public Offering", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-27T13:05:00.000+03:00", "replies_count": 0, "uuid": "19d137660eeecf0a6837e645e2d0203884cfaba9"}, "author": "", "url": "https://www.reuters.com/article/brief-onconova-therapeutics-announces-pr/brief-onconova-therapeutics-announces-pricing-of-25-mln-upsized-underwritten-public-offering-idUSASC09Y0G", "ord_in_thread": 0, "title": "BRIEF-Onconova Therapeutics Announces Pricing Of $25 Mln Upsized Underwritten Public Offering", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "brief-onconova therapeutics", "sentiment": "negative"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "onconova therapeutics inc", "sentiment": "none"}, {"name": "mln upsized underwritten public offering reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 06 AM / Updated 8 minutes ago BRIEF-Onconova Therapeutics Announces Pricing Of $25 Mln Upsized Underwritten Public Offering Reuters Staff\nApril 27 (Reuters) - Onconova Therapeutics Inc:\n* ONCONOVA THERAPEUTICS ANNOUNCES PRICING OF $25.0 MILLION UPSIZED UNDERWRITTEN PUBLIC OFFERING\n* ONCONOVA THERAPEUTICS- PRICED PUBLIC OFFERING OF 58.8 MILLION SHARES OF COMMON STOCK & WARRANTS AT $0.425 PER SHARE & ACCOMPANYING PREFERRED STOCK WARRANT Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-04-27T13:05:00.000+03:00", "crawled": "2018-04-27T13:19:42.029+03:00", "highlightTitle": ""}